2028 Pharma Pharmaceutical manufacturing 
European Pharmaceutical Review
OCTOBER 12, 2023
September 2023 saw a wave of new pharmaceutical manufacturing facility expansions and launches across Europe. Research by the Confederation of British Industry (CBI) , released in September this year, highlighted progress for UK manufacturing in its latest Industrial Trends Survey. Kerry, Ireland.
European Pharmaceutical Review
MARCH 25, 2024
The facility is planned to be operational by 2028, Astellas said. Today marks a significant achievement for our company and reflects our continued commitment to expansion and innovation in the region,” declared Hideki Shima, Chief Manufacturing Officer, Astellas Pharma.
Clarivate
AUGUST 20, 2024
In 2026, CMS will select up to 15 additional Part B or Part D drugs for negotiations that take effect in 2028, and up to 20 additional drugs every year thereafter (Part B covers physician-administered drugs, including infusions of complex biologics).
Expert insights. Personalized for you.
104 
Let's personalize your content